Senior Manager, Global Late-Stage Partnering; Business Development

Location: Cambridge (US)

Time Type: Full time

Senior Manager, Global Late-Stage Partnering (Business Development)

Ipsen Biopharmaceuticals Inc.

Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas:
Oncology, Rare Disease and Neuroscience. Supported by nearly 100 years of development experience, with global hubs in the U.S., France and the U.K, we tackle areas of high unmet medical need through research and innovation.

Our passionate teams in more than 40 countries are focused on what matters and endeavor every day to bring medicines to patients in 88 countries. We build a workplace that champions human-centric leadership and fosters a culture of collaboration, excellence and impact. At Ipsen, every individual is empowered to be their true selves, grow and thrive alongside the company’s success. Join us on our journey towards sustainable growth, creating real impact on patients and society!

For more information, visit us at and follow our latest news on Linked In and Instagram
.

The Senior Manager, Global Late-Stage Partnering will be a member of the Global Late-Stage Partnering team and report directly to the Vice President, Head of Late-Stage Partnering.

The Senior Manager will lead and maintain Ipsen’s Late-Stage Opportunity Intelligence process across Oncology, Rare Diseases, and Neuroscience, developing a comprehensive view of the external partnering landscape and identifying and prioritizing potential business development opportunities. The role will coordinate insights from cross-functional stakeholders across R&D, Medical Affairs, Commercial, Finance, and Legal to assess the strategic fit and attractiveness of external programs and companies.

The individual will translate complex scientific, clinical, commercial, and competitive information into actionable insights, strategic analyses, and executive-level recommendations to support portfolio planning and partnering decisions. The role will also contribute to selected late-stage business development transactions, providing exposure to opportunity evaluation and transaction execution while maintaining a primary focus on opportunity intelligence, landscape management, and strategic business development support.

• Own and maintain a comprehensive, continuously updated landscape of late-stage partnering opportunities across Oncology, Rare Diseases, and Neuroscience.
• Develop and manage a systematic process for identifying, tracking, evaluating, and prioritizing external assets and companies of strategic interest.
• Monitor the external environment to identify emerging opportunities, competitive developments, strategic transactions, and shifts in market dynamics that may impact Ipsen’s business development priorities.
• Establish and maintain tools, databases, dashboards, and reporting mechanisms that provide visibility into the external opportunity universe.
• Serve as the internal owner of the external opportunity universe and ensure opportunity assessments remain current, organized, and actionable.

• Track, analyze, and maintain a forward-looking view of key clinical, regulatory, commercial, corporate, and financing milestones for programs and companies of strategic interest.
• Proactively communicate important developments and their potential implications to the Global Late-Stage Partnering team and relevant internal stakeholders.

• Build and maintain strong working relationships with leaders and subject matter experts across the Oncology, Rare Diseases, and Neuroscience…